Navigation Links
Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
Date:1/20/2012

BOULDER, Colo. and PORTLAND, Ore., Jan. 20, 2012 /PRNewswire/ -- Boulder Diagnostics Inc. and Portland State University (PSU) announced today the entry into a license and collaboration agreement to develop rapid diagnostic tests for homocysteine and related compounds based on a highly specific dye technology developed at PSU. Under the agreement Boulder will finance further research at the Department of Chemistry, and PSU will be entitled to royalties on future sales of the licensed technology. Further details were not disclosed.

The innovative and highly specific dye technology developed in the laboratory of Prof. Robert Strongin at PSU enables the development of rapid diagnostic tests for homocysteine and related compounds. The new dye technology will be used in medical tests to help determine indicators for a variety of diseases, including cancer, Alzheimer's, Parkinson's, cystic fibrosis, and HIV.

"The groundbreaking technology of Prof. Strongin and his team can form the basis for a new line of products," says Wolfgang Pieken, CEO of Boulder Diagnostics Inc.

"We are excited to adapt our innovative detection chemistry to rapid diagnostic tests with Boulder Diagnostics," comments Robert Strongin, Professor of Chemistry at Portland State University.

Editor's note

For further information, please contact:

Boulder Diagnostics: Wolfgang Pieken, CEO
6395 Gunpark Drive, Ste W - Boulder, CO 80301
Phone: 720.897.6276 - info@boulderdiagnostics.com
http://www.boulderdiagnostics.com

Portland State University: Joseph Janda, Director of Innovation & Intellectual Property
PO Box 751 - Portland, OR 97207-0751
Phone: 503.725.8454 - iia@pdx.edu
http://www.pdx.edu

About Boulder Diagnostics

Boulder Diagnostics Inc. provides new diagnostic solutions to undeserved or underperforming disease diagnostics areas. It currently markets novel specific antibody reagents for the diagnosis of parasite infections.

About Portland State University (PSU)

Located in Portland, Oregon, PSU has about 30,000 undergraduate and graduate students. PSU's motto is "Let Knowledge Serve the City," and it provides every student with opportunities to work with businesses, schools and organizations on real-world projects. Its downtown campus exhibits PSU's commitment to sustainability through green buildings and business practice. Sustainability is incorporated into much of PSU's curriculum.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Boulder Diagnostics Inc.; Portland State University
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CU-Boulder python study may have implications for human heart health
2. Novel CU-Boulder technique shrinks size of nanotechnology circuitry
3. Ultrafast lasers give CU-Boulder researchers a snapshot of electrons in action
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
8. S.E.D. Labs to be Acquired by Quest Diagnostics
9. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
(Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
Breaking Biology Technology:
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):